Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants

References

• Greenberg PE, Kessler RC, Birnbaum HG,. et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465-75
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Stiglin LE, Finkelstein SN,. et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-18
   PubMed Web of Science ®Google Scholar
• Bradvik L, Mattisson C, Bogren M,. et al. Long-term suicide risk of depression in the Lundby cohort 1947–1997 – severity and gender. Acta Psychiatr Scand 2008;117:185-91
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health: Depressions. At: http://www.nimh.nih.gov/publicat/depression.cfm#ptdep1
   Google Scholar
• Mental Health: A Report from the Surgeon General. At: http://www.surgeongeneral.gov/library/mentalhealth/home.html
   Google Scholar
• Mulsant BH, Ganguli M. Epidemiology and diagnosis of depression in late life. J Clin Psychiatry 1999;60 (Suppl 20)9-15
   PubMed Web of Science ®Google Scholar
• Barry KL, Fleming MF, Manwell LB,. et al. Prevalence of and factors associated with current and lifetime depression in older adult primary care patients. Fam Med 1998;30:366-71
   PubMedGoogle Scholar
• Lyness JM, Caine ED, King DA,. et al. Psychiatric disorders in older primary care patients. J Gen Intern Med 1999;14:249-54
   PubMed Web of Science ®Google Scholar
• Bartels SJ, Horn S, Sharkey P, Levine K. Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med 1997;27:215-31
   PubMed Web of Science ®Google Scholar
• Glasser M, Gravdal JA. Assessment and treatment of geriatric depression in primary care settings. Arch Fam Med 1997;6:433-8
   PubMedGoogle Scholar
• Schwenk TL. Diagnosis of late life depression: the view from primary care. Biol Psychiatry 2002;52:157-63
   PubMed Web of Science ®Google Scholar
• Volkers AC, Nuyen J, Verhaak PF,. et al. The problem of diagnosing major depression in geriatric primary care patients. J Affect Disord 2004;82:259-63
   PubMed Web of Science ®Google Scholar
• Krishnan KR. Biological risk factors in late life depression. Biol Psychiatry 2002;52:185-92
   PubMed Web of Science ®Google Scholar
• Wells KB, Stewart A, Hays RD,. et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989;262:914-19
   Google Scholar
• Devanand DP. Comorbid psychiatric disorders in late life depression. Biol Psychiatry 2002;52:236-42
   PubMed Web of Science ®Google Scholar
• Penninx BW, Geerlings SW, Deeg DJ,. et al. Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 1999;56:889-95
   PubMed Web of Science ®Google Scholar
• Katon WJ, Lin E, Russo J,. et al. Increased medical costs of a population-based sample of depressed geriatric patients. Arch Gen Psychiatry 2003;60:897-903
   PubMed Web of Science ®Google Scholar
• Unutzer J, Patrick DL, Simon G,. et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA 1997;277:1618-23
   Google Scholar
• Luber MP, Meyers BS, Williams-Russo PG,. et al. Depression and service utilization in geriatric primary care patients. Am J Geriatr Psychiatry 2001;9:169-76
   PubMed Web of Science ®Google Scholar
• Scolnick EM. Discovery and development of antidepressants: a perspective from a pharmaceutical discovery company. Biol Psychiatry 2002;52:154-6
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Reines EH, Guiton C,. et al. Escitalopram therapy for major depression and anxiety disorders. Ann Pharmacother 2007;41:1583-92
   PubMed Web of Science ®Google Scholar
• Burke WJ. Escitalopram. Expert Opin Investig Drugs 2002; 11:1477-86
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Andersen HF, Lam RW. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. J Psychiatry Neurosci 2006;31:122-31
   PubMed Web of Science ®Google Scholar
• Rao N. The clinical pharmacokinetics of escitalopram. Clin Pharmacokinet 2007;46:281-90
   PubMed Web of Science ®Google Scholar
• Bose A, Li D, Gandhi C. Escitalopram in the acute treatment of depressed patients aged 60 years or older. Am J Geriatr Psychiatry 2008;16:14-20
   PubMed Web of Science ®Google Scholar
• Kasper S, de Swart H, Friis Andersen H. Escitalopram in the treatment of depressed geriatric patients. Am J Geriatr Psychiatry 2005;13:884-91
   PubMed Web of Science ®Google Scholar
• Gorwood P, Weiller E, Lemming O,. et al. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 2007;15:581-93
   PubMed Web of Science ®Google Scholar
• Llorca PM, Fernandez JL. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation. Int J Clin Pract 2007;61:702-10
   PubMed Web of Science ®Google Scholar
• Murdoch D, Keam SJ. Spotlight on escitalopram in the management of major depressive disorder. CNS Drugs 2006;20:167-70
   PubMed Web of Science ®Google Scholar
• Wu E, Greenberg P, Yang E, et al. Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population. Curr Med Res Opin. 2008; 24:2587-95
   PubMed Web of Science ®Google Scholar
• Antidepressant medication management. The state of health care quality, National Committee for Quality Assurance, Washington, DC, 2006:19
   Google Scholar
• Demyttenaere K, Hemels ME, Hudry J,. et al. A cost-effectiveness model of escitalopram, citalopram, and venlafaxine as first-line treatment for major depressive disorder in Belgium. Clin Ther 2005;27:111-24
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Valuck R, Saseen J,. et al. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. CNS Drugs 2004; 18:911-32
   PubMed Web of Science ®Google Scholar
• Fernandez JL, Montgomery S, Francois C. Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder. Pharmacoeconomics 2005; 23:155-67
   PubMed Web of Science ®Google Scholar
• Croom KF, Plosker GL. Spotlight on the pharmacoeconomics of escitalopram in depression. CNS Drugs 2004;18:469-73
   PubMed Web of Science ®Google Scholar